Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | PHGDH | O43175 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | CHKA | P35790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19985059 | 0.84 | MEN1 (0.33) | MEN1HTTKMT2A | |
| SCHEMBL20130855 | 0.77 | MEN1 (0.38) | MEN1HTTKMT2ACA12CA2 | |
| SCHEMBL16405945 | 0.73 | MEN1 (0.42) | MEN1HTTKMT2ACA12CA2 | |
| SCHEMBL19984962 | 0.72 | TSHR (0.38) | MEN1KMT2AL3MBTL1ALDH1A1TSHR | |
| SCHEMBL3133237 | 0.72 | MEN1 (0.46) | MEN1HTTKMT2ACA12CA2 | |
| SCHEMBL8510220 | 0.70 | MEN1 (0.44) | MEN1HTTKMT2ACA12CA2 | |
| SCHEMBL28147756 | 0.69 | MEN1 (0.42) | MEN1HTTKMT2ACA12CA2 | |
| SCHEMBL14802977 | 0.69 | MEN1 (0.42) | MEN1HTTKMT2ACA12CA2 | |
| SCHEMBL16639210 | 0.68 | KMT2A (0.38) | MEN1HTTKMT2ACA12CA2 | |
| SCHEMBL16582959 | 0.67 | KMT2A (0.41) | MEN1HTTKMT2ACA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11584854-B2 | Compositions and methods for the deposition of silicon oxide films | VERSUM MATERIALS US, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| US-20200308416-A1 | Compositions And Methods For The Deposition Of Silicon Oxide Films | VERSUM MATERIALS US, LLC (US) | 2020-10-01 | — | — | US | disclosed |
| US-20180127592-A1 | Compositions and Methods for the Deposition of Silicon Oxide Films | VERSUM MATERIALS US, LLC (US) | 2018-05-10 | — | — | US | disclosed |
| WO-2018053129-A1 | COMPOSITIONS AND METHODS FOR THE DEPOSITION OF SILICON OXIDE FILMS | VERSUM MATERIALS US, LLC (US) | 2018-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308416-A1 | Compositions And Methods For The Deposition Of Silicon Oxide Films | SEPTIN9, SGMS1, SGMS2 | MEN1 297/4885HTT 2490/4885KMT2A 1162/4885 |
| US-20180127592-A1 | Compositions and Methods for the Deposition of Silicon Oxide Films | SEPTIN9, SGMS1, SGMS2 | MEN1 297/4885HTT 2490/4885KMT2A 1162/4885 |
| US-11584854-B2 | Compositions and methods for the deposition of silicon oxide films | SEPTIN9, SGMS1, SGMS2 | MEN1 297/4885HTT 2490/4885KMT2A 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.